110 related articles for article (PubMed ID: 16034086)
1. T cell tolerance induced by cross-reactive TCR ligands can be broken by superagonist resulting in anti-inflammatory T cell cytokine production.
Illés Z; Waldner H; Reddy J; Bettelli E; Nicholson LB; Kuchroo VK
J Immunol; 2005 Aug; 175(3):1491-7. PubMed ID: 16034086
[TBL] [Abstract][Full Text] [Related]
2. Induction of T cell anergy by low numbers of agonist ligands.
Korb LC; Mirshahidi S; Ramyar K; Sadighi Akha AA; Sadegh-Nasseri S
J Immunol; 1999 Jun; 162(11):6401-9. PubMed ID: 10352253
[TBL] [Abstract][Full Text] [Related]
3. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
Deng C; Goluszko E; Christadoss P
J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
[TBL] [Abstract][Full Text] [Related]
4. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
[TBL] [Abstract][Full Text] [Related]
5. TCR-independent pathways mediate the effects of antigen dose and altered peptide ligands on Th cell polarization.
Grakoui A; Donermeyer DL; Kanagawa O; Murphy KM; Allen PM
J Immunol; 1999 Feb; 162(4):1923-30. PubMed ID: 9973460
[TBL] [Abstract][Full Text] [Related]
6. Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells.
Nembrini C; Abel B; Kopf M; Marsland BJ
J Immunol; 2006 Jun; 176(12):7180-8. PubMed ID: 16751361
[TBL] [Abstract][Full Text] [Related]
7. Neonatal immunity develops in a transgenic TCR transfer model and reveals a requirement for elevated cell input to achieve organ-specific responses.
Li L; Legge KL; Min B; Bell JJ; Gregg R; Caprio J; Zaghouani H
J Immunol; 2001 Sep; 167(5):2585-94. PubMed ID: 11509599
[TBL] [Abstract][Full Text] [Related]
8. Threshold signaling of human Th0 cells in activation and anergy: modulation of effector function by altered TCR ligand.
Verhoef A; Lamb JR
J Immunol; 2000 Jun; 164(11):6034-40. PubMed ID: 10820288
[TBL] [Abstract][Full Text] [Related]
9. Tuning T cell activation threshold and effector function with cross-reactive peptide ligands.
Nicholson LB; Anderson AC; Kuchroo VK
Int Immunol; 2000 Feb; 12(2):205-13. PubMed ID: 10653856
[TBL] [Abstract][Full Text] [Related]
10. Differential CD3 zeta phosphorylation is not required for the induction of T cell antagonism by altered peptide ligands.
Liu H; Vignali DA
J Immunol; 1999 Jul; 163(2):599-602. PubMed ID: 10395646
[TBL] [Abstract][Full Text] [Related]
11. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
Tao X; Constant S; Jorritsma P; Bottomly K
J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
[TBL] [Abstract][Full Text] [Related]
12. Self-peptides prolong survival in murine autoimmunity via reduced IL-2/IL-7-mediated STAT5 signaling, CD8 coreceptor, and V alpha 2 down-regulation.
Gutermuth J; Nograles KE; Miyagawa F; Nelson E; Cho YH; Katz SI
J Immunol; 2009 Sep; 183(5):3130-8. PubMed ID: 19675167
[TBL] [Abstract][Full Text] [Related]
13. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
[TBL] [Abstract][Full Text] [Related]
14. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo.
Gottschalk RA; Corse E; Allison JP
J Exp Med; 2010 Aug; 207(8):1701-11. PubMed ID: 20660617
[TBL] [Abstract][Full Text] [Related]
15. The magnitude of TCR engagement is a critical predictor of T cell anergy or activation.
Mirshahidi S; Ferris LC; Sadegh-Nasseri S
J Immunol; 2004 May; 172(9):5346-55. PubMed ID: 15100274
[TBL] [Abstract][Full Text] [Related]
16. Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity.
Nicholson LB; Waldner H; Carrizosa AM; Sette A; Collins M; Kuchroo VK
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):264-9. PubMed ID: 9419364
[TBL] [Abstract][Full Text] [Related]
17. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo.
Sundstedt A; O'Neill EJ; Nicolson KS; Wraith DC
J Immunol; 2003 Feb; 170(3):1240-8. PubMed ID: 12538682
[TBL] [Abstract][Full Text] [Related]
18. Distinct requirements for C-C chemokine and IL-2 production by naive, previously activated, and anergic T cells.
Lerner CG; Horton MR; Schwartz RH; Powell JD
J Immunol; 2000 Apr; 164(8):3996-4002. PubMed ID: 10754290
[TBL] [Abstract][Full Text] [Related]
19. Anergy induction by dimeric TCR ligands.
Appel H; Seth NP; Gauthier L; Wucherpfennig KW
J Immunol; 2001 Apr; 166(8):5279-85. PubMed ID: 11290814
[TBL] [Abstract][Full Text] [Related]
20. Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity.
La Gruta NL; Turner SJ; Doherty PC
J Immunol; 2004 May; 172(9):5553-60. PubMed ID: 15100298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
